228. Secukinumab, A Human Anti-Interleukin-17A Monoclonal Antibody, Improves Active Psoriatic Arthritis and Inhibits Radiographic Progression: Efficacy and Safety Data from a Phase 3 Randomized, Multicentre, Double-Blind, Placebo-Controlled Study
Year: 2015
Type: article
Source: Lara D. Veeken
Institutions: Leiden University, The University of Queensland, Guy's and St Thomas' NHS Foundation Trust, University of Washington, Leiden University Medical Center, University of California San Diego, Swedish Medical Center, Whipps Cross University Hospital, University of Glasgow, University of Amsterdam
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2099807201
